Global Parkinson's Disease Treatments Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Parkinson's Disease Treatments market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Parkinson's Disease Treatments industry chain, the market status of Hospitals (Dopamine Agonists, Levodopa), Healthcare Institutes (Dopamine Agonists, Levodopa), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parkinson's Disease Treatments.
Regionally, the report analyzes the Parkinson's Disease Treatments markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parkinson's Disease Treatments market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parkinson's Disease Treatments market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parkinson's Disease Treatments industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Dopamine Agonists, Levodopa).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parkinson's Disease Treatments market.
Regional Analysis: The report involves examining the Parkinson's Disease Treatments market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parkinson's Disease Treatments market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parkinson's Disease Treatments:
Company Analysis: Report covers individual Parkinson's Disease Treatments players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parkinson's Disease Treatments This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Healthcare Institutes).
Technology Analysis: Report covers specific technologies relevant to Parkinson's Disease Treatments. It assesses the current state, advancements, and potential future developments in Parkinson's Disease Treatments areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parkinson's Disease Treatments market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parkinson's Disease Treatments market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Parkinson's Disease Treatments product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parkinson's Disease Treatments, with revenue, gross margin and global market share of Parkinson's Disease Treatments from 2019 to 2024.
Chapter 3, the Parkinson's Disease Treatments competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Parkinson's Disease Treatments market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson's Disease Treatments.
Chapter 13, to describe Parkinson's Disease Treatments research findings and conclusion.
Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Parkinson's Disease Treatments industry chain, the market status of Hospitals (Dopamine Agonists, Levodopa), Healthcare Institutes (Dopamine Agonists, Levodopa), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parkinson's Disease Treatments.
Regionally, the report analyzes the Parkinson's Disease Treatments markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parkinson's Disease Treatments market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parkinson's Disease Treatments market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parkinson's Disease Treatments industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Dopamine Agonists, Levodopa).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parkinson's Disease Treatments market.
Regional Analysis: The report involves examining the Parkinson's Disease Treatments market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parkinson's Disease Treatments market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parkinson's Disease Treatments:
Company Analysis: Report covers individual Parkinson's Disease Treatments players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parkinson's Disease Treatments This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Healthcare Institutes).
Technology Analysis: Report covers specific technologies relevant to Parkinson's Disease Treatments. It assesses the current state, advancements, and potential future developments in Parkinson's Disease Treatments areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parkinson's Disease Treatments market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parkinson's Disease Treatments market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Dopamine Agonists
- Levodopa
- Glutamate Antagonist
- Apomorphine
- COMT Inhibitors Anticholinergics
- MAO-B Inhibitors
- Other Drugs
- Hospitals
- Healthcare Institutes
- Others
- GSK
- Merck
- Novartis
- Teva
- Boehringer Ingelheim
- Impax
- Abbvie
- Bausch Health
- Lundbeck
- Sun Pharma
- Wockhardt
- Acadia
- UCB
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Parkinson's Disease Treatments product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parkinson's Disease Treatments, with revenue, gross margin and global market share of Parkinson's Disease Treatments from 2019 to 2024.
Chapter 3, the Parkinson's Disease Treatments competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Parkinson's Disease Treatments market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson's Disease Treatments.
Chapter 13, to describe Parkinson's Disease Treatments research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Parkinson's Disease Treatments
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Parkinson's Disease Treatments by Type
1.3.1 Overview: Global Parkinson's Disease Treatments Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Parkinson's Disease Treatments Consumption Value Market Share by Type in 2023
1.3.3 Dopamine Agonists
1.3.4 Levodopa
1.3.5 Glutamate Antagonist
1.3.6 Apomorphine
1.3.7 COMT Inhibitors Anticholinergics
1.3.8 MAO-B Inhibitors
1.3.9 Other Drugs
1.4 Global Parkinson's Disease Treatments Market by Application
1.4.1 Overview: Global Parkinson's Disease Treatments Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Healthcare Institutes
1.4.4 Others
1.5 Global Parkinson's Disease Treatments Market Size & Forecast
1.6 Global Parkinson's Disease Treatments Market Size and Forecast by Region
1.6.1 Global Parkinson's Disease Treatments Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Parkinson's Disease Treatments Market Size by Region, (2019-2030)
1.6.3 North America Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
1.6.4 Europe Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
1.6.6 South America Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Parkinson's Disease Treatments Product and Solutions
2.1.4 GSK Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Parkinson's Disease Treatments Product and Solutions
2.2.4 Merck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Parkinson's Disease Treatments Product and Solutions
2.3.4 Novartis Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Parkinson's Disease Treatments Product and Solutions
2.4.4 Teva Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Teva Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Product and Solutions
2.5.4 Boehringer Ingelheim Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Impax
2.6.1 Impax Details
2.6.2 Impax Major Business
2.6.3 Impax Parkinson's Disease Treatments Product and Solutions
2.6.4 Impax Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Impax Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Parkinson's Disease Treatments Product and Solutions
2.7.4 Abbvie Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Bausch Health
2.8.1 Bausch Health Details
2.8.2 Bausch Health Major Business
2.8.3 Bausch Health Parkinson's Disease Treatments Product and Solutions
2.8.4 Bausch Health Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bausch Health Recent Developments and Future Plans
2.9 Lundbeck
2.9.1 Lundbeck Details
2.9.2 Lundbeck Major Business
2.9.3 Lundbeck Parkinson's Disease Treatments Product and Solutions
2.9.4 Lundbeck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Lundbeck Recent Developments and Future Plans
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business
2.10.3 Sun Pharma Parkinson's Disease Treatments Product and Solutions
2.10.4 Sun Pharma Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sun Pharma Recent Developments and Future Plans
2.11 Wockhardt
2.11.1 Wockhardt Details
2.11.2 Wockhardt Major Business
2.11.3 Wockhardt Parkinson's Disease Treatments Product and Solutions
2.11.4 Wockhardt Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Wockhardt Recent Developments and Future Plans
2.12 Acadia
2.12.1 Acadia Details
2.12.2 Acadia Major Business
2.12.3 Acadia Parkinson's Disease Treatments Product and Solutions
2.12.4 Acadia Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Acadia Recent Developments and Future Plans
2.13 UCB
2.13.1 UCB Details
2.13.2 UCB Major Business
2.13.3 UCB Parkinson's Disease Treatments Product and Solutions
2.13.4 UCB Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 UCB Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Parkinson's Disease Treatments Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Parkinson's Disease Treatments by Company Revenue
3.2.2 Top 3 Parkinson's Disease Treatments Players Market Share in 2023
3.2.3 Top 6 Parkinson's Disease Treatments Players Market Share in 2023
3.3 Parkinson's Disease Treatments Market: Overall Company Footprint Analysis
3.3.1 Parkinson's Disease Treatments Market: Region Footprint
3.3.2 Parkinson's Disease Treatments Market: Company Product Type Footprint
3.3.3 Parkinson's Disease Treatments Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Parkinson's Disease Treatments Consumption Value and Market Share by Type (2019-2024)
4.2 Global Parkinson's Disease Treatments Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2024)
5.2 Global Parkinson's Disease Treatments Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
6.2 North America Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
6.3 North America Parkinson's Disease Treatments Market Size by Country
6.3.1 North America Parkinson's Disease Treatments Consumption Value by Country (2019-2030)
6.3.2 United States Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
6.3.3 Canada Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
6.3.4 Mexico Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
7.2 Europe Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
7.3 Europe Parkinson's Disease Treatments Market Size by Country
7.3.1 Europe Parkinson's Disease Treatments Consumption Value by Country (2019-2030)
7.3.2 Germany Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7.3.3 France Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7.3.5 Russia Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7.3.6 Italy Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Region
8.3.1 Asia-Pacific Parkinson's Disease Treatments Consumption Value by Region (2019-2030)
8.3.2 China Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.3 Japan Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.4 South Korea Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.5 India Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.7 Australia Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
9.2 South America Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
9.3 South America Parkinson's Disease Treatments Market Size by Country
9.3.1 South America Parkinson's Disease Treatments Consumption Value by Country (2019-2030)
9.3.2 Brazil Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
9.3.3 Argentina Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Country
10.3.1 Middle East & Africa Parkinson's Disease Treatments Consumption Value by Country (2019-2030)
10.3.2 Turkey Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
10.3.4 UAE Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Parkinson's Disease Treatments Market Drivers
11.2 Parkinson's Disease Treatments Market Restraints
11.3 Parkinson's Disease Treatments Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Parkinson's Disease Treatments Industry Chain
12.2 Parkinson's Disease Treatments Upstream Analysis
12.3 Parkinson's Disease Treatments Midstream Analysis
12.4 Parkinson's Disease Treatments Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Parkinson's Disease Treatments
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Parkinson's Disease Treatments by Type
1.3.1 Overview: Global Parkinson's Disease Treatments Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Parkinson's Disease Treatments Consumption Value Market Share by Type in 2023
1.3.3 Dopamine Agonists
1.3.4 Levodopa
1.3.5 Glutamate Antagonist
1.3.6 Apomorphine
1.3.7 COMT Inhibitors Anticholinergics
1.3.8 MAO-B Inhibitors
1.3.9 Other Drugs
1.4 Global Parkinson's Disease Treatments Market by Application
1.4.1 Overview: Global Parkinson's Disease Treatments Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Healthcare Institutes
1.4.4 Others
1.5 Global Parkinson's Disease Treatments Market Size & Forecast
1.6 Global Parkinson's Disease Treatments Market Size and Forecast by Region
1.6.1 Global Parkinson's Disease Treatments Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Parkinson's Disease Treatments Market Size by Region, (2019-2030)
1.6.3 North America Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
1.6.4 Europe Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
1.6.6 South America Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Parkinson's Disease Treatments Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Parkinson's Disease Treatments Product and Solutions
2.1.4 GSK Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Parkinson's Disease Treatments Product and Solutions
2.2.4 Merck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Parkinson's Disease Treatments Product and Solutions
2.3.4 Novartis Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Parkinson's Disease Treatments Product and Solutions
2.4.4 Teva Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Teva Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Product and Solutions
2.5.4 Boehringer Ingelheim Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Impax
2.6.1 Impax Details
2.6.2 Impax Major Business
2.6.3 Impax Parkinson's Disease Treatments Product and Solutions
2.6.4 Impax Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Impax Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Parkinson's Disease Treatments Product and Solutions
2.7.4 Abbvie Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Bausch Health
2.8.1 Bausch Health Details
2.8.2 Bausch Health Major Business
2.8.3 Bausch Health Parkinson's Disease Treatments Product and Solutions
2.8.4 Bausch Health Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bausch Health Recent Developments and Future Plans
2.9 Lundbeck
2.9.1 Lundbeck Details
2.9.2 Lundbeck Major Business
2.9.3 Lundbeck Parkinson's Disease Treatments Product and Solutions
2.9.4 Lundbeck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Lundbeck Recent Developments and Future Plans
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business
2.10.3 Sun Pharma Parkinson's Disease Treatments Product and Solutions
2.10.4 Sun Pharma Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sun Pharma Recent Developments and Future Plans
2.11 Wockhardt
2.11.1 Wockhardt Details
2.11.2 Wockhardt Major Business
2.11.3 Wockhardt Parkinson's Disease Treatments Product and Solutions
2.11.4 Wockhardt Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Wockhardt Recent Developments and Future Plans
2.12 Acadia
2.12.1 Acadia Details
2.12.2 Acadia Major Business
2.12.3 Acadia Parkinson's Disease Treatments Product and Solutions
2.12.4 Acadia Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Acadia Recent Developments and Future Plans
2.13 UCB
2.13.1 UCB Details
2.13.2 UCB Major Business
2.13.3 UCB Parkinson's Disease Treatments Product and Solutions
2.13.4 UCB Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 UCB Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Parkinson's Disease Treatments Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Parkinson's Disease Treatments by Company Revenue
3.2.2 Top 3 Parkinson's Disease Treatments Players Market Share in 2023
3.2.3 Top 6 Parkinson's Disease Treatments Players Market Share in 2023
3.3 Parkinson's Disease Treatments Market: Overall Company Footprint Analysis
3.3.1 Parkinson's Disease Treatments Market: Region Footprint
3.3.2 Parkinson's Disease Treatments Market: Company Product Type Footprint
3.3.3 Parkinson's Disease Treatments Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Parkinson's Disease Treatments Consumption Value and Market Share by Type (2019-2024)
4.2 Global Parkinson's Disease Treatments Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2024)
5.2 Global Parkinson's Disease Treatments Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
6.2 North America Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
6.3 North America Parkinson's Disease Treatments Market Size by Country
6.3.1 North America Parkinson's Disease Treatments Consumption Value by Country (2019-2030)
6.3.2 United States Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
6.3.3 Canada Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
6.3.4 Mexico Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
7.2 Europe Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
7.3 Europe Parkinson's Disease Treatments Market Size by Country
7.3.1 Europe Parkinson's Disease Treatments Consumption Value by Country (2019-2030)
7.3.2 Germany Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7.3.3 France Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7.3.5 Russia Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
7.3.6 Italy Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Region
8.3.1 Asia-Pacific Parkinson's Disease Treatments Consumption Value by Region (2019-2030)
8.3.2 China Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.3 Japan Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.4 South Korea Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.5 India Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
8.3.7 Australia Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
9.2 South America Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
9.3 South America Parkinson's Disease Treatments Market Size by Country
9.3.1 South America Parkinson's Disease Treatments Consumption Value by Country (2019-2030)
9.3.2 Brazil Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
9.3.3 Argentina Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Parkinson's Disease Treatments Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Parkinson's Disease Treatments Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Country
10.3.1 Middle East & Africa Parkinson's Disease Treatments Consumption Value by Country (2019-2030)
10.3.2 Turkey Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
10.3.4 UAE Parkinson's Disease Treatments Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Parkinson's Disease Treatments Market Drivers
11.2 Parkinson's Disease Treatments Market Restraints
11.3 Parkinson's Disease Treatments Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Parkinson's Disease Treatments Industry Chain
12.2 Parkinson's Disease Treatments Upstream Analysis
12.3 Parkinson's Disease Treatments Midstream Analysis
12.4 Parkinson's Disease Treatments Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Parkinson's Disease Treatments Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parkinson's Disease Treatments Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Parkinson's Disease Treatments Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Parkinson's Disease Treatments Consumption Value by Region (2025-2030) & (USD Million)
Table 5. GSK Company Information, Head Office, and Major Competitors
Table 6. GSK Major Business
Table 7. GSK Parkinson's Disease Treatments Product and Solutions
Table 8. GSK Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. GSK Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Parkinson's Disease Treatments Product and Solutions
Table 13. Merck Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Parkinson's Disease Treatments Product and Solutions
Table 18. Novartis Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Teva Company Information, Head Office, and Major Competitors
Table 21. Teva Major Business
Table 22. Teva Parkinson's Disease Treatments Product and Solutions
Table 23. Teva Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Teva Recent Developments and Future Plans
Table 25. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 26. Boehringer Ingelheim Major Business
Table 27. Boehringer Ingelheim Parkinson's Disease Treatments Product and Solutions
Table 28. Boehringer Ingelheim Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Boehringer Ingelheim Recent Developments and Future Plans
Table 30. Impax Company Information, Head Office, and Major Competitors
Table 31. Impax Major Business
Table 32. Impax Parkinson's Disease Treatments Product and Solutions
Table 33. Impax Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Impax Recent Developments and Future Plans
Table 35. Abbvie Company Information, Head Office, and Major Competitors
Table 36. Abbvie Major Business
Table 37. Abbvie Parkinson's Disease Treatments Product and Solutions
Table 38. Abbvie Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbvie Recent Developments and Future Plans
Table 40. Bausch Health Company Information, Head Office, and Major Competitors
Table 41. Bausch Health Major Business
Table 42. Bausch Health Parkinson's Disease Treatments Product and Solutions
Table 43. Bausch Health Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bausch Health Recent Developments and Future Plans
Table 45. Lundbeck Company Information, Head Office, and Major Competitors
Table 46. Lundbeck Major Business
Table 47. Lundbeck Parkinson's Disease Treatments Product and Solutions
Table 48. Lundbeck Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Lundbeck Recent Developments and Future Plans
Table 50. Sun Pharma Company Information, Head Office, and Major Competitors
Table 51. Sun Pharma Major Business
Table 52. Sun Pharma Parkinson's Disease Treatments Product and Solutions
Table 53. Sun Pharma Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sun Pharma Recent Developments and Future Plans
Table 55. Wockhardt Company Information, Head Office, and Major Competitors
Table 56. Wockhardt Major Business
Table 57. Wockhardt Parkinson's Disease Treatments Product and Solutions
Table 58. Wockhardt Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Wockhardt Recent Developments and Future Plans
Table 60. Acadia Company Information, Head Office, and Major Competitors
Table 61. Acadia Major Business
Table 62. Acadia Parkinson's Disease Treatments Product and Solutions
Table 63. Acadia Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Acadia Recent Developments and Future Plans
Table 65. UCB Company Information, Head Office, and Major Competitors
Table 66. UCB Major Business
Table 67. UCB Parkinson's Disease Treatments Product and Solutions
Table 68. UCB Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. UCB Recent Developments and Future Plans
Table 70. Global Parkinson's Disease Treatments Revenue (USD Million) by Players (2019-2024)
Table 71. Global Parkinson's Disease Treatments Revenue Share by Players (2019-2024)
Table 72. Breakdown of Parkinson's Disease Treatments by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Parkinson's Disease Treatments, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Parkinson's Disease Treatments Players
Table 75. Parkinson's Disease Treatments Market: Company Product Type Footprint
Table 76. Parkinson's Disease Treatments Market: Company Product Application Footprint
Table 77. Parkinson's Disease Treatments New Market Entrants and Barriers to Market Entry
Table 78. Parkinson's Disease Treatments Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Parkinson's Disease Treatments Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Parkinson's Disease Treatments Consumption Value Share by Type (2019-2024)
Table 81. Global Parkinson's Disease Treatments Consumption Value Forecast by Type (2025-2030)
Table 82. Global Parkinson's Disease Treatments Consumption Value by Application (2019-2024)
Table 83. Global Parkinson's Disease Treatments Consumption Value Forecast by Application (2025-2030)
Table 84. North America Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Parkinson's Disease Treatments Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Parkinson's Disease Treatments Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Parkinson's Disease Treatments Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Parkinson's Disease Treatments Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Parkinson's Disease Treatments Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Parkinson's Disease Treatments Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Parkinson's Disease Treatments Raw Material
Table 115. Key Suppliers of Parkinson's Disease Treatments Raw Materials
Table 1. Global Parkinson's Disease Treatments Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parkinson's Disease Treatments Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Parkinson's Disease Treatments Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Parkinson's Disease Treatments Consumption Value by Region (2025-2030) & (USD Million)
Table 5. GSK Company Information, Head Office, and Major Competitors
Table 6. GSK Major Business
Table 7. GSK Parkinson's Disease Treatments Product and Solutions
Table 8. GSK Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. GSK Recent Developments and Future Plans
Table 10. Merck Company Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Parkinson's Disease Treatments Product and Solutions
Table 13. Merck Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Parkinson's Disease Treatments Product and Solutions
Table 18. Novartis Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Teva Company Information, Head Office, and Major Competitors
Table 21. Teva Major Business
Table 22. Teva Parkinson's Disease Treatments Product and Solutions
Table 23. Teva Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Teva Recent Developments and Future Plans
Table 25. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 26. Boehringer Ingelheim Major Business
Table 27. Boehringer Ingelheim Parkinson's Disease Treatments Product and Solutions
Table 28. Boehringer Ingelheim Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Boehringer Ingelheim Recent Developments and Future Plans
Table 30. Impax Company Information, Head Office, and Major Competitors
Table 31. Impax Major Business
Table 32. Impax Parkinson's Disease Treatments Product and Solutions
Table 33. Impax Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Impax Recent Developments and Future Plans
Table 35. Abbvie Company Information, Head Office, and Major Competitors
Table 36. Abbvie Major Business
Table 37. Abbvie Parkinson's Disease Treatments Product and Solutions
Table 38. Abbvie Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbvie Recent Developments and Future Plans
Table 40. Bausch Health Company Information, Head Office, and Major Competitors
Table 41. Bausch Health Major Business
Table 42. Bausch Health Parkinson's Disease Treatments Product and Solutions
Table 43. Bausch Health Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bausch Health Recent Developments and Future Plans
Table 45. Lundbeck Company Information, Head Office, and Major Competitors
Table 46. Lundbeck Major Business
Table 47. Lundbeck Parkinson's Disease Treatments Product and Solutions
Table 48. Lundbeck Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Lundbeck Recent Developments and Future Plans
Table 50. Sun Pharma Company Information, Head Office, and Major Competitors
Table 51. Sun Pharma Major Business
Table 52. Sun Pharma Parkinson's Disease Treatments Product and Solutions
Table 53. Sun Pharma Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sun Pharma Recent Developments and Future Plans
Table 55. Wockhardt Company Information, Head Office, and Major Competitors
Table 56. Wockhardt Major Business
Table 57. Wockhardt Parkinson's Disease Treatments Product and Solutions
Table 58. Wockhardt Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Wockhardt Recent Developments and Future Plans
Table 60. Acadia Company Information, Head Office, and Major Competitors
Table 61. Acadia Major Business
Table 62. Acadia Parkinson's Disease Treatments Product and Solutions
Table 63. Acadia Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Acadia Recent Developments and Future Plans
Table 65. UCB Company Information, Head Office, and Major Competitors
Table 66. UCB Major Business
Table 67. UCB Parkinson's Disease Treatments Product and Solutions
Table 68. UCB Parkinson's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. UCB Recent Developments and Future Plans
Table 70. Global Parkinson's Disease Treatments Revenue (USD Million) by Players (2019-2024)
Table 71. Global Parkinson's Disease Treatments Revenue Share by Players (2019-2024)
Table 72. Breakdown of Parkinson's Disease Treatments by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Parkinson's Disease Treatments, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Parkinson's Disease Treatments Players
Table 75. Parkinson's Disease Treatments Market: Company Product Type Footprint
Table 76. Parkinson's Disease Treatments Market: Company Product Application Footprint
Table 77. Parkinson's Disease Treatments New Market Entrants and Barriers to Market Entry
Table 78. Parkinson's Disease Treatments Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Parkinson's Disease Treatments Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Parkinson's Disease Treatments Consumption Value Share by Type (2019-2024)
Table 81. Global Parkinson's Disease Treatments Consumption Value Forecast by Type (2025-2030)
Table 82. Global Parkinson's Disease Treatments Consumption Value by Application (2019-2024)
Table 83. Global Parkinson's Disease Treatments Consumption Value Forecast by Application (2025-2030)
Table 84. North America Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Parkinson's Disease Treatments Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Parkinson's Disease Treatments Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Parkinson's Disease Treatments Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Parkinson's Disease Treatments Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Parkinson's Disease Treatments Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Parkinson's Disease Treatments Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Parkinson's Disease Treatments Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Parkinson's Disease Treatments Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Parkinson's Disease Treatments Raw Material
Table 115. Key Suppliers of Parkinson's Disease Treatments Raw Materials
LIST OF FIGURES
Figure 1. Parkinson's Disease Treatments Picture
Figure 2. Global Parkinson's Disease Treatments Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parkinson's Disease Treatments Consumption Value Market Share by Type in 2023
Figure 4. Dopamine Agonists
Figure 5. Levodopa
Figure 6. Glutamate Antagonist
Figure 7. Apomorphine
Figure 8. COMT Inhibitors Anticholinergics
Figure 9. MAO-B Inhibitors
Figure 10. Other Drugs
Figure 11. Global Parkinson's Disease Treatments Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 12. Parkinson's Disease Treatments Consumption Value Market Share by Application in 2023
Figure 13. Hospitals Picture
Figure 14. Healthcare Institutes Picture
Figure 15. Others Picture
Figure 16. Global Parkinson's Disease Treatments Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Parkinson's Disease Treatments Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Parkinson's Disease Treatments Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Parkinson's Disease Treatments Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Parkinson's Disease Treatments Consumption Value Market Share by Region in 2023
Figure 21. North America Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Parkinson's Disease Treatments Revenue Share by Players in 2023
Figure 27. Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Parkinson's Disease Treatments Market Share in 2023
Figure 29. Global Top 6 Players Parkinson's Disease Treatments Market Share in 2023
Figure 30. Global Parkinson's Disease Treatments Consumption Value Share by Type (2019-2024)
Figure 31. Global Parkinson's Disease Treatments Market Share Forecast by Type (2025-2030)
Figure 32. Global Parkinson's Disease Treatments Consumption Value Share by Application (2019-2024)
Figure 33. Global Parkinson's Disease Treatments Market Share Forecast by Application (2025-2030)
Figure 34. North America Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Parkinson's Disease Treatments Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Parkinson's Disease Treatments Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 44. France Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Parkinson's Disease Treatments Consumption Value Market Share by Region (2019-2030)
Figure 51. China Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 54. India Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Parkinson's Disease Treatments Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Parkinson's Disease Treatments Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 68. Parkinson's Disease Treatments Market Drivers
Figure 69. Parkinson's Disease Treatments Market Restraints
Figure 70. Parkinson's Disease Treatments Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Parkinson's Disease Treatments in 2023
Figure 73. Manufacturing Process Analysis of Parkinson's Disease Treatments
Figure 74. Parkinson's Disease Treatments Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Parkinson's Disease Treatments Picture
Figure 2. Global Parkinson's Disease Treatments Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parkinson's Disease Treatments Consumption Value Market Share by Type in 2023
Figure 4. Dopamine Agonists
Figure 5. Levodopa
Figure 6. Glutamate Antagonist
Figure 7. Apomorphine
Figure 8. COMT Inhibitors Anticholinergics
Figure 9. MAO-B Inhibitors
Figure 10. Other Drugs
Figure 11. Global Parkinson's Disease Treatments Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 12. Parkinson's Disease Treatments Consumption Value Market Share by Application in 2023
Figure 13. Hospitals Picture
Figure 14. Healthcare Institutes Picture
Figure 15. Others Picture
Figure 16. Global Parkinson's Disease Treatments Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Parkinson's Disease Treatments Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Parkinson's Disease Treatments Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Parkinson's Disease Treatments Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Parkinson's Disease Treatments Consumption Value Market Share by Region in 2023
Figure 21. North America Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Parkinson's Disease Treatments Revenue Share by Players in 2023
Figure 27. Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Parkinson's Disease Treatments Market Share in 2023
Figure 29. Global Top 6 Players Parkinson's Disease Treatments Market Share in 2023
Figure 30. Global Parkinson's Disease Treatments Consumption Value Share by Type (2019-2024)
Figure 31. Global Parkinson's Disease Treatments Market Share Forecast by Type (2025-2030)
Figure 32. Global Parkinson's Disease Treatments Consumption Value Share by Application (2019-2024)
Figure 33. Global Parkinson's Disease Treatments Market Share Forecast by Application (2025-2030)
Figure 34. North America Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Parkinson's Disease Treatments Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Parkinson's Disease Treatments Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 44. France Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Parkinson's Disease Treatments Consumption Value Market Share by Region (2019-2030)
Figure 51. China Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 54. India Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Parkinson's Disease Treatments Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Parkinson's Disease Treatments Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Parkinson's Disease Treatments Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Parkinson's Disease Treatments Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Parkinson's Disease Treatments Consumption Value (2019-2030) & (USD Million)
Figure 68. Parkinson's Disease Treatments Market Drivers
Figure 69. Parkinson's Disease Treatments Market Restraints
Figure 70. Parkinson's Disease Treatments Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Parkinson's Disease Treatments in 2023
Figure 73. Manufacturing Process Analysis of Parkinson's Disease Treatments
Figure 74. Parkinson's Disease Treatments Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
